Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Recreation Days Held during Second National Polio Immunization Campaigns (2014)

 
Second National Immunization Campaign against Polio
 
During 15th -21st November 2014, the Second National Polio Immunization Campaign was implemented in collaboration with UNICEF and WHO,  through which a series of Polio Vaccination Recreation Days were planned covering different areas in Lebanon, including: Tripoli, Deir Ammar, Meniyeh Danniyeh, Bebnine, Baalbeck, Beirut, Saida and Iqlim El-Kharoub.
 
These Recreation Days achieved a greater success by reaching 96% of the Primary Health Care department's target in vaccinating children under 5 years old against polio, among which 45% of the total vaccinated children were Syrian and other nationalities.
Examples of the Recreation days held in November are:
 
Recreation Day at Riyadi Club, Beirut
On Monday, November 17th 2014 a successful Recreation Day was held for school children at Riyadi Club, Beirut. This event was organized by the Primary Health Care Department (MoPH) in collaboration with UNICEF, and attended by representatives from WHO and IMC.
During this day approximately 200 students, under the age of 5 years old, from the schools of Dar el Aytam el Islamiya and Al Makassed, were vaccinated under the supervision of Registered Nurses from Primary Health Care Centers of Dar el Fatwa, Makhzoumi Foundation, Al Makassed Charitable Society and Beirut Development Association Center.
In addition to the free polio vaccination, the participating children were entertained with clowns and lively plays performed by ‘’The Arab Puppet Theatre Foundation’’. At the end of the event, The Rotary Club distributed snacks and coloring books to the children.
 

Karakozian Primary Health Care Center
On Tuesday 18th November 2014, UNICEF conducted a documentary shooting session at Karakozian Primary Health Care Center concerning the Second National Immunization Campaign against Polio. The essential role the Ministry plays in preventing poliomyelitis disease through organizing such National Polio Vaccination Campaigns was reported. Furthermore, the proceeding of the campaign was presented and parents’ opinion regarding the campaign and the reason behind vaccinating their children was also highlighted.
 

Recreation Day at Ch’him
On Thursday, 20th November 2014 another successful Recreation Day was also held at Ch’him Educational Hall, which happened to take place simultaneously with the celebration of Lebanon’s Independence Day reflected in the attending children’s costumes and celebration spirit.
During this event, 958 children under the age of 5 years old were vaccinated against polio, attending from schools located in the region of ‘’Iqlim Kharoub’’. Out of a total of 42 private and public schools in this region, 17 schools participated, and out of 15 public schools, 8 schools attended this event.
Aside from the free polio vaccination, the children were also entertained with several activities, including: puppet shows, musical plays and songs. The children were also given coloring books and snacks at the end of the event by the Rotary Club.
 
    ...
    56
    ...
ATC Name B/G Ingredients Dosage Form Price
L04AA23 TYSABRI BioTech Natalizumab - 300mg/15ml 300mg/15ml Injectable concentrated solution L.L
L01XX44 ZALTRAP BioTech Aflibercept - 200mg/8ml 200mg/8ml Injectable concentrate for solution 63,807,499 L.L
S01LA05 EYLEA BioTech Aflibercept - 8mg/0.07ml 114.3mg/ml Injectable solution 78,332,038 L.L
L01XX44 ZALTRAP BioTech Aflibercept - 200mg/8ml 200mg/8ml Injectable concentrate for solution 63,807,499 L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution 44,309,066 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 80mg/4ml 80mg/4ml Injectable concentrated solution L.L
N02CD01 AIMOVIG BioTech Erenumab - 70mg/ml 70mg/ml Injectable solution 35,423,371 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 162mg/0.9ml 162mg/0.9ml Injectable solution L.L
N02CD02 EMGALITY BioTech Galcanezumab - 120mg/ml 120mg/ml Injectable suspension 37,250,732 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 200mg/10ml 200mg/10ml Injectable concentrated solution L.L
L01XY02 PHESGO BioTech Pertuzumab - 600mg, Trastuzumab - 600mg Injectable solution 326,054,156 L.L
L04AC07 ACTEMRA BioTech Tocilizumab - 400mg/20ml 400mg/20ml Injectable concentrated solution L.L
L01XY02 PHESGO BioTech Pertuzumab - 1200mg, Trastuzumab - 600mg Injectable solution 591,417,874 L.L
M05BX04 PROLIA BioTech Denosumab - 60mg/ml 60mg/ml Injectable solution 21,603,638 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 33,545,669 L.L
A10BJ02 SAXENDA BioTech Liraglutide - 6mg/ml 6mg/ml Injectable solution 16,747,035 L.L
M05BX06 EVENITY BioTech Romosozumab - 105mg/1.17ml 105mg/1.17ml Injectable solution 56,729,091 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 0.75mg/0.5ml 0.75mg/0.5ml Injectable solution 10,165,201 L.L
R05CB13 PULMOZYME BioTech Dornase alfa (desoxyribonuclease) - 2.5mg/2.5ml 2.5mg/2.5ml Inhalation solution 54,658,804 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 1.5mg/0.5ml 1.5mg/0.5ml Injectable solution 10,165,201 L.L
B02BD02 NOVOEIGHT BioTech Turoctocog Alfa - 500IU 500IU Injectable powder for solution+diluent 29,783,973 L.L
B02BD02 NUWIQ BioTech Coagulation Factor VIII recombinant, human (Simoctogog alfa) - 500IU 500IU Injectable powder for solution+diluent 47,418,699 L.L
B02BD02 RECOFACT VIII BioTech Moroctocog alfa - 500IU 500IU Injectable powder for solution+diluent 12,049,005 L.L
B02BD02 XYNTHA BioTech Moroctocog alfa - 500IU 500IU Injectable lyophilised powder for solution+diluent 23,067,288 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial 500IU/Vial Injectable powder for solution+diluent 38,126,657 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 1000IU/Vial 1000IU/Vial Injectable powder for solution+diluent 75,761,046 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 100mg/ml 100mg/ml Injectable solution 57,429,464 L.L
J06BD01 SYNAGIS BioTech Palivizumab - 50mg/0.5ml 50mg/0.5ml Injectable solution 38,316,693 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent 27,390,281 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 500IU 500IU Injectable powder for solution+solvent 76,080,435 L.L
    ...
    56
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025